Friday, November 21, 2008 | Register | Login |   Search      
 

Clinical Pharmacology Services

AvivoClin’s custom, state-of-the-art clinical pharmacology research unit brings together an impressive blend of experience and services. AvivoClin’s management has performed a broad spectrum of clinical studies across virtually every therapeutic area. Working with local hospitals and organizations, we offer customized solutions for our clients’ early phase clinical research needs. As part of the Azopharma Product Development Group, we can also support all of your product development needs. From preclinical and bioanalytical services to formulation and CTM manufacturing, Azopharma is your product development partner.

Phase I Clinical Services – AvivoClin provides extensive Phase I Clinical Pharmacololgy services to support new drug applications and other product development goals.
Phase II-III Clinical Services – AvivoClin also provides services to support your later phase clinical activities including proof of concept and safety studies.
Bioanalytical Support –We provide the full spectrum of analytical techniques to support your clinical studies.
Regulatory Services – We can help you navigate the regulatory process and support you in your product development goals
Formulation Services – Through our parent company, Azopharma Product Development Group, we provide full formulation services for all major dosage forms in support of your clinical pharmacology studies.
CTM Manufacturing – Through the Azopharma Product Development Group we provide full CTM manufacturing services across all major dosage forms.
Preclinical Services – Comprehensive preclinical and toxicology services to support your strategic clinical pharmacology plan.
Phase I Express™- The Azopharma Product Development Group’s novel and proprietary approach to accelerating clinical trial material development.

 
Press Releases

October 30, 2008

 Azopharma Enters Microdosing Market

 HOLLYWOOD, Fla. – Azopharma Product Development Group™ is pleased to announce its entrance into the Microdosing market. Azopharma will provide services to synthesize material amenable to microdose studies as well as formulate, administer microdoses in a clinical environment and analyze samples. Microdosing is an important growing trend among pharmaceutical and regulatory agencies around the world. This technology enables the pharmaceutical industry to save both time and money on their development process by receiving early PK and ADME data in humans.   Read More

 

 

Trade Shows

ISPE:
Boca Raton, FL
October 26-28

AAPS:
Atlanta, GA
November 17-20





Copyright 2007 AvivoClin Inc.   Terms Of Use   Privacy Statement   Site Map